医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02158 医渡科技

休市中 04-24 16:08:27

6.210

-0.120

-1.90%

最高6.420	最低6.130	成交量873.40万
今开6.420	昨收6.330	日振幅4.58%
总市值63.34亿	流通市值63.34亿	总股本10.20亿
成交额5,436万	换手率0.86%	流通股本10.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02158","market":"HK","secType":"STK","nameCN":"医渡科技","latestPrice":6.21,"timestamp":1777018107005,"preClose":6.33,"halted":0,"volume":8733956,"delay":0,"changeRate":-0.018957345971563996,"floatShares":1019999999,"shares":1019999999,"eps":-0.1277941631955871,"marketStatus":"休市中","change":-0.12,"latestTime":"04-24 16:08:27","open":6.42,"high":6.42,"low":6.13,"amount":54355054,"amplitude":0.045814,"askPrice":6.21,"askSize":21400,"bidPrice":6.2,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.09637286386786391,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":7,"adr":0,"listingDate":1610640000000,"exchange":"SEHK","adjPreClose":6.33,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":0.6013541787625144,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02158","defaultTab":"news","newsList":[{"id":"2629817179","title":"医渡科技（02158）旗下医渡智循接入DeepSeek-V4，双模型协同临床辅助体验再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629817179","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629817179?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:10","pubTimestamp":1777025439,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月24日，就在DeepSeek正式发布并开源新一代旗舰模型DeepSeek-V4预览版同日，医渡科技宣布，临床循证智能体“医渡智循”完成DeepSeek-V4与医渡大模型双基座架构的医学场景适配。如今DeepSeek-V4拥有100万Token上下文窗口，约等于40万汉字，足以装下一份完整住院病历甚至整本临床指南。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629813237","title":"医渡科技（02158）3-4倍PE背后的AI医疗价值重估新叙事","url":"https://stock-news.laohu8.com/highlight/detail?id=2629813237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629813237?lang=zh_cn&edition=full","pubTime":"2026-04-24 15:39","pubTimestamp":1777016366,"startTime":"0","endTime":"0","summary":"截止4月24日15时，在AI医疗龙头医渡科技当日十大买入经纪商中，外资占了七强，其中前六强均被处交资所垄断，引中JP摩根和摩根士丹利净买入超过50万股。这只是外资在医渡科技于4月20日发布盈喜公告后的一个缩影。2026财年上半年，医渡科技净亏损为1576万元，这意味着仅下半年，公司就实现了7076万元至8576万元的惊人盈利。从“烧钱”到“造血”，医渡科技用一份盈喜答卷，宣告了AI医疗商业化元年的到来。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","AGIX","BK1617","ARTY","BK1518","02158","AIPO","159891","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629096488","title":"医渡科技(02158)联属公司中标海南智慧健康岛建设工程项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2629096488","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629096488?lang=zh_cn&edition=full","pubTime":"2026-04-22 12:11","pubTimestamp":1776831114,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技 公布，近期，公司的联属公司医渡云(北京)技术有限公司中标海南省卫健委的海南智慧健康岛建设工程项目，项目总金额约为人民币1476万元。医渡科技是驱动中国医疗体系智能化升级的核心力量，公司以智慧决策深度赋能“医、药、险、患”全产业链，致力于使精准医疗惠及每一个人。医渡科技，以自主创新的系统级智能，创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","BK1518","BK1189","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629870631","title":"医渡科技(02158)盈利预喜：AI医疗迎来“成人礼”，千亿市值之路的底层逻辑已清晰","url":"https://stock-news.laohu8.com/highlight/detail?id=2629870631","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629870631?lang=zh_cn&edition=full","pubTime":"2026-04-21 10:51","pubTimestamp":1776739874,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月20日，医渡科技一则盈利预喜公告，为整个AI医疗赛道注入了一剂强心针。2026财年上半年，公司经调整EBITDA已达5400万元，同比翻倍，亏损同比收窄72%，盈利拐点比预期提前一年到来。中国AI医疗的“成人礼”医渡科技的这份盈喜，不应被简单解读为一份漂亮的财务成绩单。在万级疾病管理市场、千亿医疗AI赛道、以及支付改革红利的共同驱动下，这家刚刚实现盈利的公司，正站在千亿市值之路的起点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","AGIX","BK1617","CHAT","BK1518","BK1189","ARTY","AIPO","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628742657","title":"倒计时4天！医渡科技（02158）即将登陆CHIMA 2026，三大重磅新品提前剧透","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742657","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628742657?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:52","pubTimestamp":1776682374,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月24日13:00，珠海国际会展中心A座一层序厅路演区2，国内AI医疗龙头企业医渡科技将举办“从数据到决策——AI重塑医院未来”年度新品发布会。而是一套面向未来医院的系统级答案：让AI真正贯穿诊疗、运营与科研全流程，让医院从“信息化建设”迈向“智能化运行”。医渡科技此次发布的三大新品，正是基于同一套底层能力，在不同场景中的系统化展开。医渡科技正以完整的产品矩阵，推动这一跃迁。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1617","BK1189","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628974641","title":"医渡科技首次扭亏背后：巨头跨界挤压、同行围堵，行业竞争依旧激烈","url":"https://stock-news.laohu8.com/highlight/detail?id=2628974641","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628974641?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:37","pubTimestamp":1776677870,"startTime":"0","endTime":"0","summary":"公告称，主要得益于公司产品融入AI能力后持续升级，有效提升了产品价值主张及市场竞争力，由此带动核心业务板块的新订单显著增长。2021年1月，医渡科技成功在香港联交所主板挂牌上市。不过，医渡科技目前面临激烈的市场竞争，一方面有巨头跨界挤压，阿里健康、京东健康等互联网巨头，以及百度、腾讯等科技公司都在加速布局医疗AI，行业随时可能爆发价格战，进而压缩公司的毛利空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776675498618661418","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1617","02158","BK1189","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628713165","title":"花旗：维持医渡科技(02158)“买入”评级 目标价11.00港元 已实现盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2628713165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628713165?lang=zh_cn&edition=full","pubTime":"2026-04-20 10:59","pubTimestamp":1776653958,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，预计自FY27起，医渡科技收入增速将进一步提升，同时EPS将进入快速增长轨道，维持其“买入”评级。基于净现值的分部估值法，该行给予目标价11.00港元，采用12.5%的加权平均资本成本及3.0%的永续增长率。按每股口径拆分，NPV估值构成为：1)大数据平台及解决方案业务：2.8港元;2)生命科学解决方案业务：2.0港元;3)健康管理平台及解决方案业务：2.7港元;4)净现金：3.4港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628791144","title":"智通港股早知道 | 伊朗关闭霍尔木兹海峡 宁德时代(03750)拟询价转让5800万A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628791144","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628791144?lang=zh_cn&edition=full","pubTime":"2026-04-20 07:15","pubTimestamp":1776640549,"startTime":"0","endTime":"0","summary":"伊朗：关闭霍尔木兹海峡直至美国解除封锁伊朗伊斯兰革命卫队海军当地时间4月18日晚发布消息称，由于美国违反停火协议，并未解除对伊朗船只和港口的封锁，因此霍尔木兹海峡从当晚起关闭，直至美国的封锁解除。成份股数目维持50只。根据宁德时代最新收盘价，本次询价转让的股份市值超250亿元(人民币)。减持后最新持股数目约为5.52亿股，最新持股比例为20.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"abb5f8deb842b3ea755632678f9c033a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1048588211.SGD","VXUS","159982","LU1039395188.USD","LU1328277881.USD","LU1255011170.USD","JKS","BK4141","LU2360107325.USD","LU0611395673.USD","BK1221","LU2097828557.USD","LU0067412154.USD","03750","LU1993786604.SGD","02158","LU2289578879.USD","BK1566","300750","00788","LU0871576103.HKD","IE0003795394.USD","LU0181495838.USD","IE0003851619.USD","LU0039217434.USD","LU0302445910.USD","LU1997245177.USD","02039","399300","LU1242518931.SGD","SG9999001689.USD","LU1515016050.SGD","LU0469268626.HKD","HK0000181138.USD","SGXZ49509284.SGD","LU1008478684.HKD","LU1051769294.HKD","LU1770034418.SGD","BK1564","LU1769817179.HKD","LU2039709279.SGD","LU1242518857.USD","LU2294711713.HKD","LU0048580855.USD","SG9999002463.SGD","03958","LU0107464264.USD","00384","EVS.SI","LU0164865239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628583799","title":"医渡科技(02158)发盈喜 预期2026财年公司拥有人应占利润约4100万-5600万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2628583799","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628583799?lang=zh_cn&edition=full","pubTime":"2026-04-20 06:11","pubTimestamp":1776636705,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技(02158)公布，该集团预期截至2026年3月31日止财政年度取得净利润约5500万-7000万元，而2025财年净亏损约1.35亿元;及预期2026财年公司拥有人应占利润约4100万-5600万元，而2025财年则取得公司拥有人应占亏损约1.18亿元。董事会认为，预期扭亏为盈乃主要由于(i)随着集团产品融入AI能力后持续升级，从而提升集团产品价值主张及竞争力，导致集团核心业务板块的新订单显著增加;及(ii)毛利率有所提升，此乃源于升级后融入AI的产品具更高附加价值、营运效率提升及规模经济效应所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"医渡科技(02158)发盈喜 预期2026财年公司拥有人应占利润约4100万-5600万元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","02158","BK1518","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185809826","title":"医渡科技预计全年业绩向好 得益于核心业务板块新订单增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1185809826","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185809826?lang=zh_cn&edition=full","pubTime":"2026-04-20 06:06","pubTimestamp":1776636371,"startTime":"0","endTime":"0","summary":"医渡科技集团在其核心业务领域获得新订单显著增加，预计将对本财年整体业绩产生积极影响。\n公司多个主营业务板块均呈现订单增长态势，这一趋势有望推动集团财务表现达到预期目标。新订单的涌入反映了市场对公司技术服务需求的持续提升，也为未来业绩增长奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","02158","BK1518","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150117978","title":"医渡科技：预计2026财年净利润55至70百万元 扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1150117978","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150117978?lang=zh_cn&edition=full","pubTime":"2026-04-20 06:05","pubTimestamp":1776636336,"startTime":"0","endTime":"0","summary":"医渡科技4月20日晚间发布正面盈利预告，公司预计截至2026年3月31日止财政年度将实现净利润约55至70百万元；同期归属于公司股东的净利润预计约41至56百万元。\\n\\n 与之对比，2025财年公司分别录得净亏损约1.35亿元及归母净亏损约1.18亿元，显示医渡科技有望于2026财年实现由亏转盈。\\n\\n 预告数据显示仍属管理层基于未经审计合并管理账目作出的初步评估，具体财务数据有待年报披露。公司计划最迟于2026年6月底前发布经审核的年度业绩。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628209232","title":"港股医渡科技午后拉升逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628209232","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628209232?lang=zh_cn&edition=full","pubTime":"2026-04-17 13:59","pubTimestamp":1776405541,"startTime":"0","endTime":"0","summary":"4月17日，医渡科技(02158.HK)午后拉升逾7%，截至发稿涨7.17%，报6.13港元，成交额7600.51万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604173708784520.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604173708784520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1518","BK4585","BK1189","BK1617","BK4588","VXUS","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628322708","title":"港股异动 | 医渡科技(02158)午后拉升逾7% 附属近期接连中标公共卫生与肿瘤AI项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2628322708","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628322708?lang=zh_cn&edition=full","pubTime":"2026-04-17 13:55","pubTimestamp":1776405305,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医渡科技午后拉升逾7%，截至发稿，涨7.17%，报6.13港元，成交额7600.51万港元。消息面上，医渡科技宣布，附属公司医渡云（北京）技术有限公司近期接连中标两个重要项目。海南省统筹区域传染病监测预警与应急指挥信息平台(省二期)项目，总金额约1289万元人民币。海南省传染病监测预警项目属于省级公卫平台二期建设，公司在公共卫生应急管理体系的数字化能力获得政府端持续认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","02158","BK4588","AGIX","BK1189","AIPO","ARTY","BK1617","CHAT","VXUS","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627629298","title":"医渡科技(02158)中标公卫与肿瘤AI项目 东北证券给予“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627629298","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627629298?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:29","pubTimestamp":1776328166,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医疗AI领域头部企业医渡科技近期接连中标两项重要项目，展现出其在公共卫生和肿瘤专科AI领域的双重核心竞争力。东北证券15日发布研报，给予公司“增持”评级，并看好其AI解决方案商业化提速及国际化战略持续推进。截至2025年9月30日，公司现金及现金等价物、定期存款等总额达21亿元，为AI技术研发及国际化扩张提供坚实保障。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000686","CHAT","AIPO","ARTY","AGIX","02158"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2627348603","title":"医渡科技（02158）中标海南重大公卫项目 项目金额近1300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627348603","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627348603?lang=zh_cn&edition=full","pubTime":"2026-04-13 12:36","pubTimestamp":1776054962,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医渡科技近期展现出强劲的业务拓展势头。两项中标，被视为公司在医疗AI大模型商业化落地及公共卫生智能化领域的双重突破。消息面上，4月9日，医渡科技举办“医渡智循”专场投资人交流会，吸引了近百位国内外知名基金及主流券商机构代表参与。基于上述积极进展，花旗银行于近日发布研报，重申对医渡科技的“买入”评级，并给出11.00港元的目标价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","BK1518","02158","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627486415","title":"医渡科技(02158)联属公司中标省统筹区域传染病监测预警与应急指挥信息平台(海南省二期)项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2627486415","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627486415?lang=zh_cn&edition=full","pubTime":"2026-04-13 12:24","pubTimestamp":1776054272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技 发布公告，近期，本公司的联属公司医渡云(北京)技术有限公司中标省统筹区域传染病监测预警与应急指挥信息平台项目，项目总金额约为人民币1289万元。医渡科技是驱动中国医疗体系智能化升级的核心力量，我们以智慧决策深度赋能“医、药、险、患”全产业链，致力于使精准医疗惠及每一个人。医渡科技，以自主创新的系统级智能，创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","02158","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626193916","title":"花旗：给予医渡科技(02158)“买入”评级 目标价为11.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626193916","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626193916?lang=zh_cn&edition=full","pubTime":"2026-04-10 16:30","pubTimestamp":1775809836,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，基于净现值的分部加总估值法是评估医渡科技合理价值的最合适方法。公司各业务板块均具备可扩展的商业模式，并通过AI技术持续提升效率。目标价为11.00港元，对应加权平均资本成本为12.5%，永续增长率为3.0%。给予“买入”评级。花旗主要观点如下：医渡科技于2026年3月正式发布医渡智循公司首席执行官徐济铭、首席财务官封晓瑛及投资者关系负责人王晓炜于4月9日在北京举行产品说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["EWH","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626891521","title":"医渡科技(02158)投资者交流会：详解医疗AI核心壁垒，数十家机构密集关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2626891521","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626891521?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:19","pubTimestamp":1775733597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近期，国内AI医疗头部企业医渡科技因在医疗人工智能领域的深度布局，特别是其专为医生打造的循证AI助手“医渡智循”的推出，吸引了市场的广泛关注。“医疗AI的本质不是语言游戏，而是对疾病进展、患者状态进行建模，其核心是数据驱动的数字孪生。”同时，公司已在50多家医院部署了医院版AI产品，为后续大规模推广奠定了坚实基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","02158","BK1189","BK1518","150261"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152790200","title":"医渡科技更新3月股份变动月报表，回购29,374,800股并行使期权","url":"https://stock-news.laohu8.com/highlight/detail?id=1152790200","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152790200?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:12","pubTimestamp":1775733138,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年4月9日发布2026年3月股份变动月报表，报告期为截至2026年3月31日的一个月。本月公司在多个股份回购交易日共购回29,374,800股，购回价格区间约为每股HKD 5.47至HKD 5.93，相关股份均被持作库存股。此外，公司修订后的首次公开发售后股份奖励计划3月内未发行新股，仍保留16,480,050股可发行额度。公司声明遵守香港联交所《上市规则》及相关法律法规，所有本月内股份的发行与回购均获得董事会批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625496961","title":"医渡科技(02158)：联属公司中标北京肿瘤医院人工智能建设银医合作项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2625496961","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625496961?lang=zh_cn&edition=full","pubTime":"2026-04-08 06:09","pubTimestamp":1775599787,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技 发布公告，近期，公司的联属公司医渡云(北京)技术有限公司中标北京肿瘤医院人工智能建设银医合作项目，项目总金额约为人民币488万元。医渡科技是驱动中国医疗体系智能化升级的核心力量，公司以智慧决策深度赋能“医、药、险、患”全产业链，致力于使精准医疗惠及每一个人。医渡科技，以自主创新的系统级智能，创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ARTY","BK1617","02158","AGIX","BK1189","BK1518","161631","CHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0231},{"period":"1month","weight":0.2105},{"period":"3month","weight":0.018},{"period":"6month","weight":0.0819},{"period":"1year","weight":0.1458},{"period":"ytd","weight":0.1829}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医渡科技有限公司是一家主要从事提供基于大数据和人工智能（AI）技术的医疗解决方案的投资控股公司。该公司主要通过三个分部运营其业务。大数据平台和解决方案分部从事提供数据智能平台及数据分析驱动的解决方案。生命科学解决方案分部从事为药物和医疗器械的全生命周期管理提供支持，涵盖从临床开发到上市后的各个阶段。健康管理平台和解决方案分部从事提供AI赋能的健康管理解决方案。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.077386},{"month":2,"riseRate":0.666667,"avgChangeRate":0.095773},{"month":3,"riseRate":0,"avgChangeRate":-0.131056},{"month":4,"riseRate":0.5,"avgChangeRate":0.015867},{"month":5,"riseRate":0,"avgChangeRate":-0.063625},{"month":6,"riseRate":0.6,"avgChangeRate":0.067533},{"month":7,"riseRate":0.2,"avgChangeRate":-0.05605},{"month":8,"riseRate":0.2,"avgChangeRate":-0.107097},{"month":9,"riseRate":0.6,"avgChangeRate":-0.067899},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069507},{"month":11,"riseRate":0.6,"avgChangeRate":0.153719},{"month":12,"riseRate":0.6,"avgChangeRate":0.017309}],"exchange":"SEHK","name":"医渡科技","nameEN":"YIDU TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医渡科技,02158,医渡科技股票,医渡科技股票老虎,医渡科技股票老虎国际,医渡科技行情,医渡科技股票行情,医渡科技股价,医渡科技股市,医渡科技股票价格,医渡科技股票交易,医渡科技股票购买,医渡科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}